Silo Pharma attends IPAC-RS Nasal Innovation Forum, spotlights SPC-15 nose-to-brain PTSD delivery technology

• Silo Pharma will participate in the IPAC-RS 2026 Nasal Innovation Forum on Sept. 16-17, 2026, in Jersey City, New Jersey.
• Focus will be its patented nose-to-brain delivery program SPC-15 for PTSD, a core asset in its CNS pipeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090915PRIMZONEFULLFEED9823449) on September 09, 2026, and is solely responsible for the information contained therein.